Eric Lewis Krakauer, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Palliative Care | 44 | 2023 | 3493 | 5.020 |
Why?
|
| Vietnam | 11 | 2023 | 408 | 1.460 |
Why?
|
| Health Services Accessibility | 13 | 2019 | 5135 | 1.020 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2021 | 2020 | 0.990 |
Why?
|
| Terminal Care | 7 | 2021 | 1694 | 0.750 |
Why?
|
| Social Responsibility | 2 | 2016 | 388 | 0.720 |
Why?
|
| Delivery of Health Care | 8 | 2022 | 5321 | 0.680 |
Why?
|
| Extensively Drug-Resistant Tuberculosis | 1 | 2019 | 92 | 0.660 |
Why?
|
| Attitude to Death | 1 | 2021 | 382 | 0.640 |
Why?
|
| Relief Work | 1 | 2019 | 137 | 0.610 |
Why?
|
| Physicians | 4 | 2023 | 4567 | 0.600 |
Why?
|
| Pain | 7 | 2023 | 4988 | 0.600 |
Why?
|
| Altruism | 1 | 2019 | 204 | 0.600 |
Why?
|
| Hospital Bed Capacity | 1 | 2017 | 215 | 0.550 |
Why?
|
| Developing Countries | 8 | 2020 | 2815 | 0.530 |
Why?
|
| Analgesics, Opioid | 7 | 2019 | 3677 | 0.500 |
Why?
|
| Personal Autonomy | 2 | 2011 | 298 | 0.470 |
Why?
|
| World Health Organization | 6 | 2022 | 1318 | 0.440 |
Why?
|
| Specialization | 1 | 2018 | 776 | 0.440 |
Why?
|
| Death | 2 | 2021 | 678 | 0.430 |
Why?
|
| Health Personnel | 4 | 2020 | 3219 | 0.400 |
Why?
|
| Education, Medical | 3 | 2019 | 1722 | 0.400 |
Why?
|
| Antitubercular Agents | 1 | 2019 | 1320 | 0.390 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2019 | 912 | 0.390 |
Why?
|
| Ethics Committees, Clinical | 3 | 2017 | 56 | 0.390 |
Why?
|
| Quality of Life | 4 | 2021 | 12802 | 0.380 |
Why?
|
| Prejudice | 3 | 2008 | 570 | 0.380 |
Why?
|
| Terminally Ill | 3 | 2010 | 238 | 0.380 |
Why?
|
| Health Policy | 5 | 2017 | 2661 | 0.380 |
Why?
|
| Patient Rights | 1 | 2010 | 126 | 0.350 |
Why?
|
| Neoplasms | 11 | 2023 | 21696 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2023 | 3922 | 0.340 |
Why?
|
| Ethics, Medical | 3 | 2000 | 792 | 0.330 |
Why?
|
| Resuscitation Orders | 3 | 2014 | 269 | 0.320 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2020 | 2232 | 0.310 |
Why?
|
| Morphine | 2 | 2014 | 657 | 0.290 |
Why?
|
| Mediterranean Region | 2 | 2022 | 47 | 0.270 |
Why?
|
| Vulnerable Populations | 2 | 2021 | 686 | 0.260 |
Why?
|
| Social Justice | 2 | 2008 | 457 | 0.260 |
Why?
|
| Hiccup | 1 | 2005 | 9 | 0.260 |
Why?
|
| Patient Care | 1 | 2011 | 640 | 0.260 |
Why?
|
| Humans | 62 | 2023 | 744366 | 0.250 |
Why?
|
| Attitude of Health Personnel | 4 | 2023 | 3841 | 0.240 |
Why?
|
| Double Effect Principle | 1 | 2003 | 14 | 0.230 |
Why?
|
| Suicide, Assisted | 1 | 2003 | 64 | 0.210 |
Why?
|
| Hypnotics and Sedatives | 2 | 2000 | 1162 | 0.210 |
Why?
|
| Philosophy, Medical | 3 | 2003 | 79 | 0.200 |
Why?
|
| Vomiting | 1 | 2005 | 637 | 0.200 |
Why?
|
| HIV Infections | 4 | 2021 | 16715 | 0.200 |
Why?
|
| Trust | 3 | 2007 | 505 | 0.200 |
Why?
|
| Physician-Patient Relations | 3 | 2012 | 3229 | 0.200 |
Why?
|
| Caregivers | 6 | 2023 | 2095 | 0.190 |
Why?
|
| Barrett Esophagus | 1 | 2005 | 494 | 0.190 |
Why?
|
| Zimbabwe | 1 | 2020 | 129 | 0.190 |
Why?
|
| International Agencies | 2 | 2019 | 240 | 0.190 |
Why?
|
| Government Programs | 1 | 2022 | 275 | 0.180 |
Why?
|
| Advance Care Planning | 1 | 2007 | 662 | 0.180 |
Why?
|
| Opioid-Related Disorders | 1 | 2014 | 2064 | 0.180 |
Why?
|
| Decision Making | 4 | 2023 | 3888 | 0.170 |
Why?
|
| Hemangioendothelioma | 1 | 2000 | 121 | 0.170 |
Why?
|
| Pain, Intractable | 1 | 2000 | 130 | 0.170 |
Why?
|
| Esophagus | 1 | 2005 | 1019 | 0.170 |
Why?
|
| Health Services Needs and Demand | 3 | 2016 | 1410 | 0.170 |
Why?
|
| Freedom | 1 | 1998 | 69 | 0.160 |
Why?
|
| Dissent and Disputes | 2 | 2014 | 141 | 0.160 |
Why?
|
| Patient Education as Topic | 3 | 2020 | 2278 | 0.160 |
Why?
|
| Poverty | 2 | 2014 | 2660 | 0.160 |
Why?
|
| Humanism | 1 | 1998 | 89 | 0.160 |
Why?
|
| Self-Assessment | 1 | 2019 | 390 | 0.150 |
Why?
|
| Education, Pharmacy | 1 | 2016 | 35 | 0.140 |
Why?
|
| Ethics Consultation | 1 | 2017 | 52 | 0.140 |
Why?
|
| Internationality | 2 | 2020 | 1002 | 0.140 |
Why?
|
| Patient Advocacy | 1 | 1998 | 353 | 0.140 |
Why?
|
| Education, Nursing | 1 | 2016 | 82 | 0.140 |
Why?
|
| Uganda | 1 | 2020 | 1237 | 0.140 |
Why?
|
| Group Processes | 1 | 1997 | 225 | 0.130 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2014 | 980 | 0.130 |
Why?
|
| Schizophrenia, Paranoid | 1 | 1995 | 104 | 0.130 |
Why?
|
| Morals | 1 | 2018 | 285 | 0.130 |
Why?
|
| Esophageal Neoplasms | 1 | 2005 | 1585 | 0.130 |
Why?
|
| Rwanda | 1 | 2017 | 703 | 0.130 |
Why?
|
| Fatal Outcome | 3 | 2010 | 1851 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 19905 | 0.120 |
Why?
|
| Health Priorities | 1 | 2017 | 380 | 0.120 |
Why?
|
| Population Dynamics | 1 | 2016 | 302 | 0.120 |
Why?
|
| India | 1 | 2020 | 2197 | 0.120 |
Why?
|
| Minority Groups | 1 | 2002 | 1221 | 0.120 |
Why?
|
| Drug and Narcotic Control | 1 | 2014 | 146 | 0.110 |
Why?
|
| Developed Countries | 1 | 2016 | 437 | 0.110 |
Why?
|
| Income | 1 | 2022 | 1913 | 0.110 |
Why?
|
| Self Report | 2 | 2021 | 3553 | 0.110 |
Why?
|
| Professional-Family Relations | 1 | 1997 | 482 | 0.110 |
Why?
|
| Social Support | 2 | 2020 | 2118 | 0.110 |
Why?
|
| Radiation Oncology | 1 | 2019 | 555 | 0.110 |
Why?
|
| Psychometrics | 1 | 2021 | 3003 | 0.100 |
Why?
|
| Strabismus | 1 | 1995 | 287 | 0.100 |
Why?
|
| Female | 15 | 2023 | 380193 | 0.100 |
Why?
|
| Jamaica | 2 | 2021 | 51 | 0.100 |
Why?
|
| Fellowships and Scholarships | 2 | 2014 | 1078 | 0.100 |
Why?
|
| Rural Health Services | 1 | 2014 | 379 | 0.100 |
Why?
|
| Management Audit | 1 | 2010 | 23 | 0.090 |
Why?
|
| Nurses | 1 | 2020 | 2462 | 0.090 |
Why?
|
| Heroin | 1 | 2010 | 117 | 0.090 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 1637 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2020 | 2212 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 25039 | 0.090 |
Why?
|
| Hospitals | 1 | 2023 | 3954 | 0.080 |
Why?
|
| Drug Utilization | 1 | 2014 | 1183 | 0.080 |
Why?
|
| Living Wills | 1 | 2007 | 19 | 0.080 |
Why?
|
| Medication Adherence | 1 | 2019 | 2063 | 0.080 |
Why?
|
| Adult | 9 | 2022 | 214052 | 0.080 |
Why?
|
| Child | 4 | 2023 | 77709 | 0.080 |
Why?
|
| Physician's Role | 2 | 2011 | 943 | 0.070 |
Why?
|
| Stress, Psychological | 2 | 2019 | 4245 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 6364 | 0.070 |
Why?
|
| Health Plan Implementation | 1 | 2010 | 352 | 0.070 |
Why?
|
| Hospitals, General | 3 | 2017 | 749 | 0.070 |
Why?
|
| Anxiety | 1 | 2021 | 4293 | 0.070 |
Why?
|
| Middle Aged | 11 | 2021 | 213390 | 0.070 |
Why?
|
| Drugs, Essential | 1 | 2007 | 73 | 0.070 |
Why?
|
| Prevalence | 2 | 2021 | 15221 | 0.070 |
Why?
|
| Male | 14 | 2023 | 350115 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2014 | 2488 | 0.070 |
Why?
|
| Politics | 1 | 1992 | 791 | 0.070 |
Why?
|
| Duodenal Obstruction | 1 | 2005 | 24 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2017 | 2494 | 0.060 |
Why?
|
| Chronic Disease | 3 | 2020 | 9145 | 0.060 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 1438 | 0.060 |
Why?
|
| Octreotide | 1 | 2005 | 145 | 0.060 |
Why?
|
| Certification | 1 | 2007 | 423 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 5388 | 0.060 |
Why?
|
| Medicine | 1 | 1992 | 946 | 0.060 |
Why?
|
| Haloperidol | 1 | 2005 | 397 | 0.060 |
Why?
|
| Antiemetics | 1 | 2005 | 177 | 0.060 |
Why?
|
| Social Sciences | 1 | 2003 | 45 | 0.060 |
Why?
|
| Public Health | 1 | 2016 | 2602 | 0.060 |
Why?
|
| Oregon | 1 | 2003 | 140 | 0.050 |
Why?
|
| Legislation as Topic | 1 | 2003 | 80 | 0.050 |
Why?
|
| Dyspnea | 1 | 2010 | 1303 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 3154 | 0.050 |
Why?
|
| Health Promotion | 1 | 2014 | 2205 | 0.050 |
Why?
|
| Endoscopy, Digestive System | 1 | 2005 | 345 | 0.050 |
Why?
|
| Cerebral Infarction | 1 | 2007 | 1011 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 818 | 0.050 |
Why?
|
| Nausea | 1 | 2005 | 674 | 0.050 |
Why?
|
| Critical Illness | 1 | 2014 | 2670 | 0.050 |
Why?
|
| Psychology | 1 | 2003 | 356 | 0.050 |
Why?
|
| Endosonography | 1 | 2005 | 610 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 3020 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 57776 | 0.050 |
Why?
|
| Caribbean Region | 1 | 2020 | 194 | 0.040 |
Why?
|
| Iran | 1 | 2022 | 710 | 0.040 |
Why?
|
| Suicide | 1 | 2010 | 1474 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 4851 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2015 | 4369 | 0.040 |
Why?
|
| Latin America | 1 | 2020 | 380 | 0.040 |
Why?
|
| Existentialism | 1 | 1998 | 33 | 0.040 |
Why?
|
| Personhood | 1 | 1998 | 30 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 77460 | 0.040 |
Why?
|
| Haiti | 1 | 2020 | 553 | 0.040 |
Why?
|
| Massachusetts | 3 | 2017 | 8662 | 0.040 |
Why?
|
| Moral Obligations | 1 | 1998 | 96 | 0.040 |
Why?
|
| Aged | 6 | 2021 | 163288 | 0.040 |
Why?
|
| Academies and Institutes | 1 | 2020 | 317 | 0.040 |
Why?
|
| Culture | 1 | 2002 | 633 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2005 | 1951 | 0.040 |
Why?
|
| Age Factors | 1 | 2014 | 18373 | 0.040 |
Why?
|
| Attitude | 1 | 2022 | 776 | 0.040 |
Why?
|
| Knowledge | 1 | 1998 | 181 | 0.040 |
Why?
|
| Systems Integration | 1 | 2019 | 440 | 0.040 |
Why?
|
| China | 1 | 2023 | 2245 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 3616 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 56429 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2005 | 1524 | 0.040 |
Why?
|
| Equipment and Supplies | 1 | 2019 | 281 | 0.030 |
Why?
|
| Perphenazine | 1 | 1995 | 34 | 0.030 |
Why?
|
| Hospice Care | 1 | 2003 | 672 | 0.030 |
Why?
|
| Health | 1 | 1998 | 394 | 0.030 |
Why?
|
| Health Care Rationing | 1 | 2019 | 437 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 2005 | 1332 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 1790 | 0.030 |
Why?
|
| Family Health | 1 | 2000 | 1281 | 0.030 |
Why?
|
| Malawi | 1 | 2014 | 282 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 4839 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2000 | 1011 | 0.030 |
Why?
|
| Health Education | 1 | 2020 | 1056 | 0.030 |
Why?
|
| Bioethical Issues | 1 | 2014 | 124 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 12961 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2000 | 1547 | 0.030 |
Why?
|
| Organizational Case Studies | 1 | 2014 | 299 | 0.030 |
Why?
|
| Nepal | 1 | 2014 | 295 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 3338 | 0.030 |
Why?
|
| Geography | 1 | 2014 | 669 | 0.030 |
Why?
|
| History, 17th Century | 1 | 1992 | 111 | 0.030 |
Why?
|
| History of Medicine | 1 | 1992 | 35 | 0.030 |
Why?
|
| Legislation, Drug | 1 | 2014 | 206 | 0.030 |
Why?
|
| Leadership | 1 | 2021 | 1357 | 0.030 |
Why?
|
| History, Ancient | 1 | 1992 | 212 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2014 | 724 | 0.030 |
Why?
|
| Family | 1 | 2023 | 3147 | 0.030 |
Why?
|
| History, 18th Century | 1 | 1992 | 213 | 0.030 |
Why?
|
| Social Medicine | 1 | 1992 | 62 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2003 | 2291 | 0.020 |
Why?
|
| Cultural Diversity | 1 | 2014 | 359 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2014 | 599 | 0.020 |
Why?
|
| History, 19th Century | 1 | 1992 | 720 | 0.020 |
Why?
|
| Dopamine | 1 | 1995 | 1591 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 11126 | 0.020 |
Why?
|
| Association | 1 | 2007 | 53 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2012 | 970 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7785 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2760 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2014 | 2682 | 0.020 |
Why?
|
| Informed Consent | 1 | 2012 | 995 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 1995 | 2147 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 2007 | 354 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2014 | 3420 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2007 | 413 | 0.020 |
Why?
|
| Rural Population | 1 | 2014 | 2207 | 0.010 |
Why?
|
| Congresses as Topic | 1 | 2009 | 764 | 0.010 |
Why?
|
| United States | 2 | 2021 | 69872 | 0.010 |
Why?
|
| Linear Models | 1 | 2014 | 5953 | 0.010 |
Why?
|
| Vasculitis | 1 | 2007 | 519 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7282 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2012 | 1470 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2000 | 9240 | 0.010 |
Why?
|
| Comorbidity | 1 | 1995 | 10388 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8385 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2011 | 1831 | 0.010 |
Why?
|
| Brain | 1 | 2007 | 26388 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12244 | 0.010 |
Why?
|
| Fatigue | 1 | 2007 | 1531 | 0.010 |
Why?
|
| Risk | 1 | 2012 | 9688 | 0.010 |
Why?
|
| Headache | 1 | 2007 | 1226 | 0.010 |
Why?
|
| Registries | 1 | 2012 | 8091 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15535 | 0.010 |
Why?
|
| Risk Assessment | 1 | 1997 | 23336 | 0.010 |
Why?
|
| Migraine Disorders | 1 | 2007 | 1620 | 0.010 |
Why?
|
| Skin | 1 | 2007 | 4372 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2009 | 3309 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 4925 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29060 | 0.010 |
Why?
|
| Mycobacterium | 1 | 1948 | 249 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 8861 | 0.000 |
Why?
|
| Drug Therapy | 1 | 1948 | 497 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 35425 | 0.000 |
Why?
|
| Bacteria | 1 | 1948 | 2115 | 0.000 |
Why?
|